Real-World Experience and Optimization of Outpatient Chimeric Antigen Receptor T Cell Therapy

被引：8
|
作者：
McGann, Mary [1 ]
Davis, James A. [1 ]
Gaffney, Kelly J. [1 ]
Smith, Deidra [1 ]
Edwards, Kathy [1 ]
Hess, Brian T. [1 ]
Hashmi, Hamza [1 ]
机构：
[1] Med Univ South Carolina, Charleston, SC USA
来源：
TRANSPLANTATION AND CELLULAR THERAPY | 2022年 / 28卷 / 09期
关键词：
LISOCABTAGENE MARALEUCEL;
D O I：
10.1016/j.jtct.2022.06.021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：583 / 585
页数：3
相关论文
共 50 条
  • [1] A REAL-WORLD CASE OF SECOND CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
    Joseph, Jacinth
    Marjoncu, Dennis
    Holman, Kori
    Leidy, Sara
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A247 - A247
  • [2] Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed and refractory multiple myeloma: real-world experience
    Hansen, Doris
    Sidana, Surbhi
    Peres, Lauren
    Leitzinger, Christelle Colin
    Shune, Leyla
    Shrewsbury, Alexandria
    Gonzalez, Rebecca
    Sborov, Douglas
    Wagner, Charlotte
    Hashmi, Hamza
    Kocoglu, Mehmet
    Atrash, Shebli
    Simmons, Gary
    Kalariya, Nilesh
    Ferreri, Christopher
    Afrough, Aimaz
    Kansagra, Ankit
    Voorhees, Peter
    Baz, Rachid
    Khouri, Jack
    Alsina, Melissa
    McGuirk, Joseph
    Locke, Frederick
    Patel, Krina
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S2 - S3
  • [3] Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center
    Alexander D. Heini
    Ulrike Bacher
    Marie-Noëlle Kronig
    Gertrud Wiedemann
    Urban Novak
    Sacha Zeerleder
    Behrouz Mansouri Taleghani
    Michael Daskalakis
    Thomas Pabst
    [J]. Bone Marrow Transplantation, 2022, 57 : 1010 - 1012
  • [4] Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center
    Heini, Alexander D.
    Bacher, Ulrike
    Kronig, Marie-Noelle
    Wiedemann, Gertrud
    Novak, Urban
    Zeerleder, Sacha
    Mansouri Taleghani, Behrouz
    Daskalakis, Michael
    Pabst, Thomas
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (06) : 1010 - 1012
  • [5] Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data
    Lambert, Jerome
    Di Blasi, Roberta
    Rabian, Florence
    Dourthe, Marie-Emilie
    Baruchel, Andre
    Thieblemont, Catherine
    Boissel, Nicolas
    Levy, Vincent
    Picat, Marie-Quitterie
    Chevret, Sylvie
    [J]. HEMASPHERE, 2023, 7 (06):
  • [6] Ocular toxicities in chimeric antigen receptor T-cell therapy: a real-world study leveraging FAERS database
    Zhao, Na
    Hu, Fangyuan
    Zhai, Yinghong
    Ye, Xia
    Ruan, Yiming
    Liu, Zhen
    Wang, Zhiyan
    Shen, Wei
    Yuan, Lei
    [J]. IMMUNOTHERAPY, 2024, 16 (03) : 161 - 172
  • [7] Incidence and Outcomes of Pneumocystis Pneumonia Following Chimeric Antigen Receptor T-Cell Therapy: A Real-World Analysis
    Wang, Jiasheng
    Daunov, Michael
    Cooper, Brenda W.
    [J]. BLOOD, 2023, 142
  • [8] Adverse events during chimeric antigen receptor T-cell (CAR-T) therapy for hematologic malignancies (HM): Real-world, US patient experience
    Kish, Jonathan
    Liu, Rachael
    Vennam, Srinivasa
    Lussier, Courtney
    Pfeffer, Daniel
    Nayak, Pratibha
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] OPTIMIZATION OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR MEDULLOBLASTOMA
    Nellan, Anandani
    Rota, Christopher
    Warren, Katherine
    Lee, Daniel
    [J]. NEURO-ONCOLOGY, 2016, 18 : 106 - 106
  • [10] Real-world treatment of large B-cell lymphoma with chimeric antigen receptor T-cell therapy after loncastuximab tesirine
    Hamadani, Mehdi
    Lucero, Melanie
    Devos, Jakob D.
    Chen, Lei
    [J]. EJHAEM, 2024, 5 (05): : 1110 - 1113
12345